Chiome Bioscience

Chiome Bioscience, Inc. is a biotechnology company established in 2005 that specializes in the R&D of antibody drug discovery and technology. One of our major businesses is the drug discovery business, and we are promoting R&D of antibody drug pipelines with the aim of licensing them to pharmaceutical companies. We also have another business, the drug discovery support business, where we develop partnerships and contract services with pharmaceuticals, diagnostics, biotechs, and academic institutions, utilizing our own antibody generation (ADLib® system) and optimization technologies, and protein expression technologies.